These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11109104)

  • 1. Effect of spontaneous and induced mutations on outer membrane proteins and lipopolysaccharides of Proteus penneri strain 357.
    Kustos I; Tóth V; Kilár F; Kocsis B; Emódy L
    Adv Exp Med Biol; 2000; 485():177-81. PubMed ID: 11109104
    [No Abstract]   [Full Text] [Related]  

  • 2. Capillary electrophoretic analysis of wild type and mutant Proteus penneri outer membrane proteins.
    Kustos I; Tóth V; Kocsis B; Kerepesi I; Emody L; Kilár F
    Electrophoresis; 2000 Aug; 21(14):3020-7. PubMed ID: 11001319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential virulence factors of Proteus bacilli.
    Rózalski A; Sidorczyk Z; Kotełko K
    Microbiol Mol Biol Rev; 1997 Mar; 61(1):65-89. PubMed ID: 9106365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity among clinical isolates of Proteus penneri detected by random amplified polymorphic DNA analysis.
    Hoffmann G; Gajdos G; Czakó M; Kerényi M; Tóth V; Emõdy L; Tomcsányi T
    Zentralbl Bakteriol; 1998 Nov; 288(3):351-60. PubMed ID: 9861679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic activity and invasiveness in strains of Proteus penneri.
    Rozalski A; Kotełko K
    J Clin Microbiol; 1987 Jun; 25(6):1094-6. PubMed ID: 3597752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and serological classification of a collection of Proteus penneri clinical strains.
    Drzewiecka D; Zych K; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2004; 52(2):121-8. PubMed ID: 15179326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proteus bacilli: features and virulence factors].
    Rózalski A; Kwil I; Torzewska A; Baranowska M; Staczek P
    Postepy Hig Med Dosw (Online); 2007; 61():204-19. PubMed ID: 17507868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and serological characterization of the lipopolysaccharide from Proteus penneri 20 and classification of the cross-reacting Proteus penneri strains 10, 16, 18, 20, 32 and 45 in Proteus serogroup O17.
    Sidorczyk Z; Toukach FV; Zych K; Arbatsky NP; Drzewiecka D; Ziółkowski A; Shashkov AS; Knirel YA
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):345-50. PubMed ID: 12455869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swarming growth and resistance of Proteus penneri and Proteus vulgaris strains to normal human serum.
    Kwil I; Kaźmierczak D; Różalski A
    Adv Clin Exp Med; 2013; 22(2):165-75. PubMed ID: 23709372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of a Proteus penneri clinical isolate with a unique O-antigen structure to a new Proteus serogroup, O80.
    Siwińska M; Levina EA; Ovchinnikova OG; Drzewiecka D; Shashkov AS; Różalski A; Knirel YA
    Carbohydr Res; 2015 Apr; 407():131-6. PubMed ID: 25771295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological classification and epitope specificity of Proteus penneri S29 lipopolysaccharide.
    Zych K; Siwińska M; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2005; 53(6):540-5. PubMed ID: 16407787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The genus Proteus. Pathogenic and epidemiologic aspects].
    Gómez A; Baquero F; Nombela C
    Enferm Infecc Microbiol Clin; 1991; 9(7):425-32. PubMed ID: 1799614
    [No Abstract]   [Full Text] [Related]  

  • 13. [Investigation of hydrophobicity of Proteus vulgaris strains and ability of Proteus vulgaris and Proteus penneri strains to penetrate bladder membrane HCV T-29 cells ].
    Bartodziejska B; Błaszczyk A; Wykrota M; Kwil I; Babicka D; Rózalski A
    Med Dosw Mikrobiol; 2002; 54(4):335-45. PubMed ID: 12650056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The genus Proteus. Pathogenic and epidemiologic aspects].
    Gómez A; Baquero F; Nombela C
    Enferm Infecc Microbiol Clin; 1991 Oct; 9(8):498-505. PubMed ID: 1805954
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of a rat model for induction of pyelonephritis with cell wall deficiency variants of Proteus mirabilis.
    Hughes BF; Schwarz H; Gomolka D
    Invest Urol; 1972 Jul; 10(1):10-3. PubMed ID: 4556712
    [No Abstract]   [Full Text] [Related]  

  • 16. Expanded clinical spectrum of infections caused by Proteus penneri.
    Krajden S; Fuksa M; Petrea C; Crisp LJ; Penner JL
    J Clin Microbiol; 1987 Mar; 25(3):578-9. PubMed ID: 3571463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical properties of Proteus penneri lipopolysaccharides--one of the major Proteus sp. virulence factors.
    Palusiak A
    Carbohydr Res; 2013 Oct; 380():16-22. PubMed ID: 23896159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the O-specific polysaccharide of a serologically separate strain Proteus penneri 2 from a new proposed serogroup O66.
    Arbatsky NP; Shashkov AS; Toukach FV; Moll H; Zych K; Knirel YA; Zähringer U; Sidorczyk Z
    Eur J Biochem; 1999 Apr; 261(2):392-7. PubMed ID: 10215848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 16S-23S rDNA internal transcribed spacer regions in four Proteus species.
    Cao B; Wang M; Liu L; Zhou Z; Wen S; Rozalski A; Wang L
    J Microbiol Methods; 2009 Apr; 77(1):109-18. PubMed ID: 19318046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of iron-regulated outer membrane proteins in uropathogenic Proteus mirabilis and its relationship with heme uptake.
    Piccini CD; Barbé FM; Legnani-Fajardo CL
    FEMS Microbiol Lett; 1998 Sep; 166(2):243-8. PubMed ID: 9770281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.